Princeton Separations Scientific

Executive Summary

Princeton Separations Scientific (PSS) is a family-owned biotechnology manufacturer specializing in molecular separation tools for genomics and proteomics research. Founded in 1978 and rebranded after a post-COVID restructuring, the company produces DNA purification products, including spin columns and the novel Electro-Sep/Gene Stix system, used in sequencing, diagnostics, and forensic testing. PSS serves research labs, hospitals, forensic labs, and government agencies globally, leveraging its manufacturing expertise to offer reliable, cost-effective solutions. With a robust product portfolio and a focus on downstream applications, PSS is well-positioned to maintain its niche in the competitive life sciences tools market. However, as a private company with limited publicly available financial data, its growth trajectory and market share remain speculative. The company's long history and loyal customer base provide a stable foundation, but scaling and innovation will be key to capturing new opportunities in the expanding molecular diagnostics space.

Upcoming Catalysts (preview)

• Q3 2026Commercial launch or expansion of Electro-Sep/Gene Stix system into new applications or geographic markets70% success
• Q4 2026Strategic partnership or distribution agreement with a larger diagnostics or life sciences company60% success